<DOC>
	<DOCNO>NCT02211638</DOCNO>
	<brief_summary>The puropose study gain understand actual use candesartan cilexetil ( Blopress ) patient hypertension , examine change parameter blood pressure .</brief_summary>
	<brief_title>Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」</brief_title>
	<detailed_description>This special drug use surveillance plan gain understand actual use candesartan cilexetil new anti-hypertensive treatment environment angiotensin receptor blocker ( ARB ) combination drug become commercially available . The surveillance also investigate background factor patient continue treatment candesartan cilexetil patient switch candesartan cilexetil ARB combination drug , well change parameter blood pressure . The usual adult dosage Candesartan cilexetil 4 8 mg , administer orally , daily.The dose may increase 12 mg necessary . However , treatment start 2 mg daily patient renal impairment dose may increase 8 mg necessary .</detailed_description>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Hypertensive patient 1 . Inpatients 2 . Patients dialysis ( plan ) 3 . Patients history coronary artery disease/cerebrovascular disorder within 6 month 4 . Patients ≥ class III New York Heart Association ( NYHA ) classification functional classification heart failure 5 . Patients prescribed candesartan ( drug/Ecard/Unisia ) past 6 . Patients pregnant may possibly become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>